Follow
David Stockley
David Stockley
Verified email at soton.ac.uk
Title
Cited by
Cited by
Year
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value
BA Walker, PE Leone, L Chiecchio, NJ Dickens, MW Jenner, KD Boyd, ...
Blood, The Journal of the American Society of Hematology 116 (15), e56-e65, 2010
4662010
Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple …
MW Jenner, PE Leone, BA Walker, FM Ross, DC Johnson, D Gonzalez, ...
Blood, The Journal of the American Society of Hematology 110 (9), 3291-3300, 2007
1792007
The t (14; 20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance
FM Ross, L Chiecchio, GP Dagrada, RKM Protheroe, DM Stockley, ...
haematologica 95 (7), 1221, 2010
1342010
Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context
L Chiecchio, GP Dagrada, AH Ibrahim, ED Cabanas, RKM Protheroe, ...
haematologica 94 (12), 1708, 2009
1152009
Frequent upregulation of MYC in plasma cell leukemia
L Chiecchio, GP Dagrada, HE White, MR Towsend, RKM Protheroe, ...
Genes, Chromosomes and Cancer 48 (7), 624-636, 2009
872009
Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case
L Chiecchio, GP Dagrada, RKM Protheroe, DM Stockley, AG Smith, ...
haematologica 94 (7), 1024, 2009
582009
Heterogeneity in the prognostic significance of 12p deletion and chromosome 5 amplification in multiple myeloma
NP HR, P CI, P HR, P HR
Journal of Clinical Oncology 29 (2), e37-e39, 2011
132011
Abnormalities of 16q in Multiple Myeloma Are Associated with Poor Prognosis: 500K Gene Mapping and Expression Correlations Identify Two Potential Tumor Suppressor Genes, WWOX …
MW Jenner, PE Leone, BA Walker, DC Johnson, L Chiecchio, ...
Blood 108 (11), 110, 2006
52006
Gain of 1q21 Does Not Predict for Immediate Progression in MGUS.
L Chiecchio, GP Dagrada, ED Cabanas, RKM Protheroe, DM Stockley, ...
Blood 114 (22), 123, 2009
32009
Defining high risk myeloma using co-segregating FISH variables; results of MRC Myeloma IX
KD Boyd, FM Ross, WJ Tapper, L Chiecchio, GP Dagrada, R Protheroe, ...
Blood 116 (21), 1907, 2010
22010
Deletion 13, Detected by Metaphase Analysis, Is Not a Significant Prognostic Indicator In Myeloma
FM Ross, L Chiecchio, GP Dagrada, WJ Tapper, ZJ Konn, KL Cheung, ...
Blood 116 (21), 2980, 2010
2010
ARRAY CGH HIGHLIGHTS GENETIC DIFFERENCES BETWEEN MGUS AND MYELOMA
L Chiecchio, G Dagrada, RKM Protheroe, DM Stockley, GJ Morgan, ...
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 93, 74-74, 2008
2008
Plasma cell immunophenotype is highly predictive of the level of chromosomal abnormalities in patients with MGUS
AC Rawstron, L Chiecchio, R de Tute, GP Dagrada, RKM Protheroe, ...
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 92 (6), 198-198, 2007
2007
Deletion of 16q identified by FISH is an independent adverse prognostic marker in multiple myeloma
MW Jenner, PE Leone, BA Walker, DC Johnson, L Chiecchio, ...
British Journal of Haematology 137 (Supp/1), 1, 2007
2007
IGH rearrangements in plasma cell dyscrasias
FM Ross, L Chiecchio, GP Dagrada, RKM Protheroe, M Nightingale, ...
Haematologica 92 (6, Supplement 2), 102-103, 2007
2007
Stable asymptomatic myeloma and MGUS in the presence of T (4; 14)
FM Ross, L Chiecchio, RKM Protheroe, GP Dagrada, DM Stockley, ...
Haematologica 92 (Supplement 1), 330-331, 2007
2007
Chromosome 1 abnormalities in myeloma and MGUS
L Chiecchio, GP Dagrada, RKM Protheroe, PE Leone, M Nightingale, ...
Haematologica 92 (6), 103, 2007
2007
The system can't perform the operation now. Try again later.
Articles 1–17